Skip to main content

. 1983 Apr;47(4):545–547. doi: 10.1038/bjc.1983.86

Distribution of 4'epi-doxorubicin in human tissues.

C Italia, L Paglia, A Trabattoni, S Luchini, F Villas, L Beretta, G Marelli, N Natale

PMCID: PMC2011320 PMID: 6573906

545

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Benjamin R. S., Riggs C. E., Jr, Bachur N. R. Plasma pharmacokinetics of adriamycin and its metabolites in humans with normal hepatic and renal function. Cancer Res. 1977 May;37(5):1416–1420. [PubMed] [Google Scholar]
Bonfante V., Bonadonna G., Villani F., Di Fronzo G., Martini A., Casazza A. M. Preliminary phase I study of 4'-epi-adriamycin. Cancer Treat Rep. 1979 May;63(5):915–918. [PubMed] [Google Scholar]
Broggini M., Colombo T., Martini A., Donelli M. G. Studies on the comparative distribution and biliary excretion of doxorubicin and 4'-epi-doxorubicin in mice and rats. Cancer Treat Rep. 1980 Aug-Sep;64(8-9):897–904. [PubMed] [Google Scholar]
Chan K. K., Cohen J. L., Gross J. F., Himmelstein K. J., Bateman J. R., Tsu-Lee Y., Marlis A. S. Prediction of adriamycin disposition in cancer patients using a physiologic, pharmacokinetic model. Cancer Treat Rep. 1978 Aug;62(8):1161–1171. [PubMed] [Google Scholar]
Donelli M. G., Barbieri B., Erba E., Pacciarini M. A., Salmona A., Garattini S., Morasca L. In vitro uptake and cytotoxicity of adriamycin in primary and metastatic Lewis lung carcinoma. Eur J Cancer. 1979 Sep;15(9):1121–1129. doi: 10.1016/0014-2964(79)90128-2. [DOI] [PubMed] [Google Scholar]
Rosso R., Ravazzoni C., Esposito M., Sala R., Santi L. Plasma and urinary levels of adriamycin in man. Eur J Cancer. 1972 Aug;8(4):455–459. doi: 10.1016/0014-2964(72)90132-6. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES